Bevacizumab in combination with a taxane for the first-line treatment of metastatic breast cancer

  • Technology appraisal guidance
  • TA214
  • Published: 
Download guidance (PDF)

5 Recommendations for further research

5.1

Further research designed to investigate differences in health-related quality of life and the clinical effectiveness of bevacizumab in subgroups, such as those with prior taxane exposure, would be particularly useful.